Nutraceutical Focus Martek is a biotechnology company specializing in nutritional products and microalgae-derived oils (DHA and ARA) for infant development and lifelong health, presenting opportunities to cross-sell advanced nutrition solutions, dietary supplements, and fortification programs to partners in baby food, pediatric nutrition, and wellness sectors.

Fermentation Expertise Pioneering fermentation technology and patented microalgae strains signal potential collaborations with contract manufacturers, ingredient suppliers, and pharma/biotech firms seeking scalable, sustainable production capabilities for specialty oils and bioactives.

Global Footprint With multiple U.S. facilities and a global footprint, there are opportunities to engage in supply agreements, co-development projects, or regional partnerships to optimize logistics, reduce time-to-market, and expand distribution of DHA/ARA-rich products.

Strategic M&A Signals Recent asset divestiture to CBS ArcSafe and active partnerships imply a dynamic corporate strategy; business development can explore collaboration, licensing, or acquisition conversations to unlock value from Martek’s IP, fermentation platforms, and R&D pipeline.

Financial Scale & Partners Revenue in the tens of millions and a mid-sized employee base position Martek as a growth-stage, niche player suitable for tier-2 supplier relationships, joint ventures, or program-based deals with larger clients in nutraceuticals, infant nutrition, and health-science markets.